BRAIN Biotech AG

BATS-CHIXE:BNND Stock Report

Market Cap: €130.2m

BRAIN Biotech Future Growth

Future criteria checks 4/6

BRAIN Biotech is forecast to grow earnings and revenue by 70.9% and 11.9% per annum respectively while EPS is expected to grow by 69.5% per annum.

Key information

70.9%

Earnings growth rate

69.5%

EPS growth rate

Chemicals earnings growth16.5%
Revenue growth rate11.9%
Future return on equityn/a
Analyst coverage

Low

Last updatedn/a

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:BNND - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2025735N/A92
9/30/202468-1-214
9/30/202358-6-7-34
9/30/202250-9-12-44
6/30/202248-8-3-2N/A
3/31/202244-8-4-1N/A
12/31/202141-4-3-2N/A
9/30/202139-5-5-4N/A
6/30/202137-6-5-2N/A
3/31/202137-6-6-5N/A
12/31/202037-11-9-6N/A
9/30/202039-10-8-5N/A
6/30/202041-9-11-4N/A
3/31/202041-12-11-5N/A
12/31/201941-12-10-4N/A
9/30/201940-11-10-3N/A
6/30/201939-9-5-4N/A
3/31/201937-7-9-5N/A
12/31/201833-7-8-7N/A
9/30/201829-8-7-5N/A
6/30/201827-9-9-8N/A
3/31/201825-8-7-6N/A
12/31/201726-7-6-4N/A
9/30/201726-10-7-6N/A
6/30/201726-14-7-6N/A
3/31/201726-14-8-6N/A
12/31/201625-17-8-6N/A
9/30/201625-15-10-9N/A
6/30/201624-10-8-8N/A
3/31/201624-9N/A-6N/A
12/31/201524-7N/A-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BNND is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: BNND is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BNND is expected to become profitable in the next 3 years.

Revenue vs Market: BNND's revenue (11.9% per year) is forecast to grow faster than the UK market (4% per year).

High Growth Revenue: BNND's revenue (11.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BNND's Return on Equity is forecast to be high in 3 years time


Discover growth companies